BATM ADVANCED COMMUN ......... ::
Seite 1 von 1 Neuester Beitrag: 25.04.21 01:55 | ||||
Eröffnet am: | 26.08.15 09:27 | von: buran | Anzahl Beiträge: | 21 |
Neuester Beitrag: | 25.04.21 01:55 | von: Birgitylfoa | Leser gesamt: | 8.639 |
Forum: | Hot-Stocks | Leser heute: | 1 | |
Bewertet mit: | ||||
The Company is committed to high standards of corporate governance and the Board is accountable to the Company’s shareholders for such governance. The Board reviews carefully all new regulations relating to the principles of good corporate governance and practice and endeavours to apply them where applicable. It also reviews carefully any comments received from independent reviewing agencies and shareholders and communicates with them directly. The Company believes that the combination of the experience of its Chairman, Peter Sheldon, in the UK markets and its senior non-executive Vice Chairman, Gideon Chitayat, in the Israeli market provides the Company with the relevant leadership to address its position as an Israeli company that is traded on the UK exchange. As a result of recent amendments in the Israeli Companies Law on corporate governance which came into effect during 2012, as well as comments received during 2012 from corporate governance consultants of UK institutional and pension investors, the Company has implemented various improvements in its corporate governance policies, as described in more detail in this Report. The main thrust of these changes are thrusts of these changes is designed to: http://www.batm.com/index.php?page=corporate-governance
into Strategic Joint Venture in China
Donnerstag, 30.06.2016 08:00
HOD HASHARON, Israel --(BUSINESS WIRE)--
BATM Advanced Communications Limited (LSE: BVC) (“BATM” or “the Group”), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its wholly-owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has entered into an investment agreement and a strategic joint venture with its Chinese partner, Egens Biotechnology Company Ltd. (“Egens”), a leading biotechnology company combining biological material development and diagnostic reagent manufacturing. http://www.ariva.de/news/...eceive-investment-and-enters-into-5797835
Donnerstag, 30.06.2016 08:00
HOD HASHARON, Israel --(BUSINESS WIRE)--
BATM Advanced Communications Limited (LSE: BVC) (“BATM” or “the Group”), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its wholly-owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has entered into an investment agreement and a strategic joint venture with its Chinese partner, Egens Biotechnology Company Ltd. (“Egens”), a leading biotechnology company combining biological material development and diagnostic reagent manufacturing. http://www.ariva.de/news/...eceive-investment-and-enters-into-5797835
Apr 27, 2017
File: ANNUAL FINANCIAL REPORT 27.04.17 - DTR 6.3.5 Disclosure.pdf [149.77 KB]
ANNUAL FINANCIAL REPORT - DTR 6.3.5 Disclosure http://www.batm.com/index.php?page=news&article=263
File: ANNUAL FINANCIAL REPORT 27.04.17 - DTR 6.3.5 Disclosure.pdf [149.77 KB]
ANNUAL FINANCIAL REPORT - DTR 6.3.5 Disclosure http://www.batm.com/index.php?page=news&article=263